Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12872c2cdd0696eb7ab790a29ce45082 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-22 |
filingDate |
1993-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb2f1b48f837339978d2c541e5bf1ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d445e6713e7756fb87d5b57764d9aa32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a45fbeb6fb6b33332ad3f9a536184b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cafd54064888870a317e8e3b7a51aae7 |
publicationDate |
1994-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0625504-A1 |
titleOfInvention |
Stable and crystaline form of Bezafibrate |
abstract |
A crystal form of 2- [4- [2- (4-chlorobenzoylamino) ethyl] phenoxy] -2-methylpropionic acid (INN: bezafibrate) is described as the β-form 3389 cm⁻¹ 847 cm⁻¹ 1740 cm⁻¹ 821 cm⁻¹ 1328 cm⁻¹ 618 cm⁻¹ 606 cm⁻¹ is marked. Due to its crystalline properties, the form offers advantages in galenic processing into solid pharmaceutical forms. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1117744-C |
priorityDate |
1993-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |